Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study.

Saved in:
Bibliographic Details
Title: Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study.
Authors: Endrikat J; Bayer HealthCare Pharmaceuticals, 13353 Berlin, Germany. jan.endrikat@bayer.com, Parke S, Trummer D, Serrani M, Duijkers I, Klipping C
Source: Contraception [Contraception] 2013 Feb; Vol. 87 (2), pp. 227-34. Date of Electronic Publication: 2012 Sep 17.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0234361 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0518 (Electronic) Linking ISSN: 00107824 NLM ISO Abbreviation: Contraception Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0518
DOI:10.1016/j.contraception.2012.07.008